Adinath Ayurvedic Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -5.07%
(FY 2020)
- Profit -26.15%
(FY 2020)
- Ebitda 45.43%
(FY 2020)
- Net Worth 20.66%
(FY 2020)
- Total Assets 31.34%
(FY 2020)
About Adinath Ayurvedic Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajinder Bedi, Manisha Bedi, and Kabir Bedi serve as directors at the Company.
- CIN/LLPIN
U24232DL2011PTC227181
- Company No.
227181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Adinath Ayurvedic Research Private Limited offer?
Adinath Ayurvedic Research Private Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine, Hair Care Capsules, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Pharmaceutical Tablets, Slimming Pill, Pharmaceutical Capsules, Fat Burning Capsules, Herbal Supplements.
Who are the key members and board of directors at Adinath Ayurvedic Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajinder Bedi  | Director | 09-Nov-2011 | Current |
| Manisha Bedi | Director | 09-Nov-2011 | Current |
| Kabir Bedi | Director | 19-Mar-2022 | Current |
Financial Performance of Adinath Ayurvedic Research.
Adinath Ayurvedic Research Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 5.07% decrease. The company also saw a substantial fall in profitability, with a 26.15% decrease in profit. The company's net worth Soared by an impressive increase of 20.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adinath Ayurvedic Research?
In 2019, Adinath Ayurvedic Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adinath Ayurvedic Research?
Unlock and access historical data on people associated with Adinath Ayurvedic Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adinath Ayurvedic Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adinath Ayurvedic Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
